Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sanstar is an Indian manufacturer of maize-based specialty products and ingredient solutions serving food, pharmaceutical, animal nutrition, cosmetics, paper, adhesive, and other industrial markets. The company operates large-scale wet milling and derivative manufacturing facilities in Dhule, Maharashtra and Kutch, Gujarat, and markets products including native starches, modified starches, maltodextrin, liquid glucose, dextrose monohydrate, sorbitol, and related co-products. In healthcare-related end markets, Sanstar appears to participate primarily as a commercial supplier of pharmaceutical excipients and functional ingredients rather than as a drug developer. It is a publicly traded, active company listed in India under the symbol SANSTAR. The business is best characterized as a specialty ingredients and excipients company with some exposure to pharma and healthcare applications, not a biotech therapeutics company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sanstar.